ProShares Ultra Nasdaq Biotechnology (BIB) is an ETF managed by ProShares. Its largest position is GILEAD SCIENCES, INC. (GILD), representing 6.48% of fund assets.
ProShares Ultra Nasdaq Biotechnology Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BIB
- Type:
- ETF
- Manager:
- ProShares
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
GILEAD SCIENCES, INC.
|
6.48% | $5,943,700.80 | 39,904 |
|
-
APPLIED MATERIALS INC /DE
|
6.34% | $5,817,987.37 | 4,291 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
6.27% | $5,753,788.23 | 11,581 |
|
-
AMGEN INC
|
6.15% | $5,642,293.76 | 14,536 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
4.06% | $3,727,784.23 | 4,769 |
|
-
APPLIED MATERIALS INC /DE
|
3.61% | $3,308,295.63 | 2,484 |
|
-
APPLIED MATERIALS INC /DE
|
2.89% | $2,651,090.10 | 2,639 |
|
-
APPLIED MATERIALS INC /DE
|
2.85% | $2,613,913.81 | 6,179 |
|
-
APPLIED MATERIALS INC /DE
|
2.63% | $2,414,689.32 | 3,646 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.21% | $2,031,144.92 | 6,101 |
|
-
INVESCO GOVERNMENT & AGENCY PORTFOLIO
|
1.81% | $1,662,868.50 | 1,662,869 |
|
-
REPURCHASE AGREEMENT
|
1.71% | $1,567,850.91 | 1,567,851 |
|
-
INSMED Inc
|
1.60% | $1,470,601.84 | 9,848 |
|
-
BIOGEN INC.
|
1.42% | $1,299,388.68 | 6,774 |
|
-
ARGENX SE
|
1.12% | $1,030,740.48 | 1,344 |
|
-
UNITED THERAPEUTICS Corp
|
1.09% | $1,001,753.20 | 1,988 |
|
-
Moderna, Inc.
|
1.05% | $966,349.23 | 18,039 |
|
-
ILLUMINA, INC.
|
1.03% | $948,615.30 | 7,055 |
|
-
Roivant Sciences Ltd.
|
1.01% | $929,379.16 | 32,114 |
|
-
INCYTE CORP
|
1.00% | $918,012.55 | 9,065 |
|
-
Royalty Pharma plc
|
0.99% | $911,677.09 | 19,729 |
|
-
Revolution Medicines, Inc.
|
0.99% | $910,732.54 | 8,927 |
|
-
Viatris Inc
|
0.87% | $794,022.19 | 53,183 |
|
-
REPURCHASE AGREEMENT
|
0.85% | $776,975.55 | 776,976 |
|
-
REPURCHASE AGREEMENT
|
0.85% | $776,975.55 | 776,976 |
|
-
Ascendis Pharma A/S
|
0.72% | $661,972.50 | 2,835 |
|
-
NEUROCRINE BIOSCIENCES INC
|
0.66% | $608,879.00 | 4,604 |
|
-
IONIS PHARMACEUTICALS INC
|
0.66% | $606,920.85 | 7,479 |
|
-
Sanofi
|
0.65% | $594,576.54 | 12,219 |
|
-
BridgeBio Pharma, Inc.
|
0.64% | $591,472.56 | 8,897 |
|
-
Medpace Holdings, Inc.
|
0.64% | $587,739.76 | 1,301 |
|
-
Summit Therapeutics Inc.
|
0.62% | $570,281.25 | 34,375 |
|
-
Guardant Health, Inc.
|
0.61% | $560,958.60 | 5,974 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
0.60% | $547,606.83 | 8,871 |
|
-
EXELIXIS, INC.
|
0.59% | $545,506.86 | 12,381 |
|
-
Jazz Pharmaceuticals plc
|
0.58% | $533,196.12 | 2,806 |
|
-
BioNTech SE
|
0.56% | $514,663.87 | 4,669 |
|
-
REPURCHASE AGREEMENT
|
0.51% | $466,185.33 | 466,185 |
|
-
REPURCHASE AGREEMENT
|
0.51% | $466,185.33 | 466,185 |
|
-
BeOne Medicines Ltd.
|
0.50% | $460,903.46 | 1,454 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.49% | $452,736.00 | 1,048 |
|
-
ImmunityBio, Inc.
|
0.49% | $444,804.18 | 45,481 |
|
-
Tempus AI, Inc.
|
0.46% | $425,041.50 | 7,982 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.43% | $396,766.17 | 6,271 |
|
-
Praxis Precision Medicines, Inc.
|
0.42% | $388,946.25 | 1,155 |
|
-
REPURCHASE AGREEMENT
|
0.42% | $388,487.77 | 388,488 |
|
-
Axsome Therapeutics, Inc.
|
0.42% | $381,372.03 | 2,327 |
|
-
HALOZYME THERAPEUTICS, INC.
|
0.41% | $377,547.90 | 5,430 |
|
-
Vaxcyte, Inc.
|
0.41% | $373,156.56 | 6,044 |
|
-
Krystal Biotech, Inc.
|
0.40% | $369,081.96 | 1,339 |
Advertisement (320x50)